Clin2
NCT06168175Possibly a fitNot yet recruiting

Lactate for recent major depression

Major Depressive Disorder

Treatments studied

Part of Mental health clinical trials.

This trial tests if adding lactate (a natural body chemical) to your regular treatment can help people recently hospitalized for major depression feel better faster. It involves having an IV line for 5 days.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
46 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have recently (within the last week) been hospitalized for major depression.
  • You are between 18 and 65 years old.
  • You are fluent in French.
  • You have had no more than 3 prior major depressive episodes in your life.
  • You are willing to have a small IV line in your arm for 5 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04637620Recruiting· Phase 2
NMDA-based treatment study for major depression

This Phase 2 trial tests whether an NMDA-targeted treatment can improve symptoms of major depressive disorder (MDD). You may be able to join if your depression diagnosis and symptom score fit, and you meet several safety and study-following requirements.

Taichung
NCT05136755Recruiting· Phase 2
NMDA treatment for depression that did not improve

This trial studies an NMDA-based treatment for people with major depressive disorder who did not respond to at least one antidepressant. It may help by changing brain signaling linked to depression symptoms.

Taichung
NCT06701760Not yet recruiting· Phase 2
Sodium Lactate for Severe Brain Injury

This study tests whether a medicine called sodium lactate can help people with severe traumatic brain injury. It is for adults who have a very serious head injury and are in the intensive care unit.

NCT06634069Recruiting· Phase 2
Testing a new approach for septic shock patients

This trial tests a special fluid management strategy for people in septic shock—a serious infection that causes very low blood pressure. It aims to improve blood flow to organs and help you recover.

Pilsen, Czech Republic
NCT07747389Not yet recruiting· Phase 3
Lumateperone for major depressive disorder

This study tests whether the drug lumateperone can help people with moderate to severe depression. If you join, you may receive the study drug or a placebo (a pill with no active medicine) to see if it improves your symptoms.

NCT05004610Recruiting· Phase 2
Hypertonic lactate treatment after cardiac arrest

This trial studies whether giving a specific IV fluid (hypertonic lactate) soon after resuscitation from cardiac arrest can improve recovery. It is for adults who remain in a deep unresponsive state after return of spontaneous circulation.

Brussels, Belgium

Hear when a new Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.